|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ren SC, Chen R and Sun YH: Prostate cancer
research in China. Asian J Androl. 15:350–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sooriakumaran P, Nyberg T, Akre O,
Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G and
Wiklund P: Comparative effectiveness of radical prostatectomy and
radiotherapy in prostate cancer: Observational study of mortality
outcomes. BMJ. 348:g15022014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kahn B, Collazo J and Kyprianou N:
Androgen receptor as a driver of therapeutic resistance in advanced
prostate cancer. Int J Biol Sci. 10:588–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi X, Gipp J, Dries M and Bushman W:
Prostate progenitor cells proliferate in response to castration.
Stem Cell Res. 13:154–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ianni M, Porcellini E, Carbone I,
Potenzoni M, Pieri AM, Pastizzaro CD, Benecchi L and Licastro F:
Genetic factors regulating inlammation and DNA methylation
associated with prostate cancer. Prostate Cancer Prostatic Dis.
16:56–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu JB, Dai CM, Su XY, Cao L, Qin R and
Kong QB: Gene microarray assessment of multiple genes and signal
pathways involved in androgen-dependent prostate cancer becoming
androgen independent. Asian Pac J Cancer Prev. 15:9791–9795. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sullenger BA and Nair S: From the RNA
world to the clinic. Science. 352:1417–1420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu K, Yang L, Li C, Zhu CH, Wang X, Yao Y
and Jia YJ: MicroRNA-146a enhances Helicobacter pylori induced cell
apoptosis in human gastric cancer epithelial cells. Asian Pac J
Cancer Prev. 15:5583–5586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao S, Ye X, Xiao L, Lian X, Feng Y, Li F
and Li L: MiR-26a inhibits prostate cancer progression by
repression of Wnt5a. Tumor Biol. 35:9725–9733. 2014. View Article : Google Scholar
|
|
11
|
Shao Y, Li P, Zhu ST, Yue JP, Ji XJ, Ma D,
Wang L, Wang YJ, Zong Y, Wu YD and Zhang ST: MiR-26a and miR-144
inhibit proliferation and metastasis of esophageal squamous cell
cancer by inhibiting cyclooxygenase-2. Oncotarget. 7:15173–15186.
2016.PubMed/NCBI
|
|
12
|
Hickman OJ, Smith RA, Dasgupta P, Rao SN,
Nayak S, Sreenivasan S, Vyakarnam A and Galustian C: Expression of
two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine
apoptosis through regulation of PTGS2/COX-2. Br J Cancer.
114:1235–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia RP, Xu LW, Su Q, Zhao JH, Li WC, Wang
F and Xu Z: Cyclooxygenase-2 expression is dependent upon epidermal
growth factor receptor expression or activation in androgen
independent prostate cancer. Asian J Androl. 10:758–764. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang D, Zhu X, Cui C, Dong M, Jiang H, Li
Z, Liu Z, Zhu W and Wang JG: Discovery of novel acetohydroxyacid
synthase inhibitors as active agents against Mycobacterium
tuberculosis by virtual screening and bioassay. J Chem Inf Model.
53:343–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Liu XX, He JR, Zhou CX, Guo M, He
M, Li MF, Chen GQ and Zhao Q: Pathologically decreased miR-26a
antagonizes apoptosis and facilitates carcinogenesis by targeting
MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao J, Li L, Wu M, Liu M and Xie X, Guo J,
Tang H and Xie X: MiR-26a inhibits proliferation and migration of
breast cancer through repression of MCL-1. PLoS One. 8:e651382013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q
and Xu K: MiR-26a enhances metastasis potential of lung cancer
cells via AKT pathway by targeting PTEN. Biochim Biophys Acta.
1822:1692–1704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T and Seki N: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015.PubMed/NCBI
|
|
19
|
Sun WH, Zhu F, Chen GS, Su H, Luo C, Zhao
QS, Zhang Y, Shao Y, Sun J, Zhou SM, et al: Blockade of
cholecystokinin-2 receptor and cyclooxygenase-2 synergistically
induces cell apoptosis and inhibits the proliferation of human
gastric cancer cells in vitro. Cancer Lett. 263:302–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bieniek J, Childress C, Swatski MD and
Yang W: COX-2 inhibitors arrest prostate cancer cell cycle
progression by down-regulation of kinetochore/centromere proteins.
Prostate. 74:999–1011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walther U, Emmrich K, Ramer R, Mittag N
and Hinz B: Lovastatin lactone elicits human lung cancer cell
apoptosis via a COX-2/PPARγ-dependent pathway. Oncotarget.
7:10345–10362. 2016.PubMed/NCBI
|
|
22
|
Hao Y, Gu X, Zhao Y, Greene S, Sha W,
Smoot DT, Califano J, Wu TC and Pang X: Enforced expression of
miR-101 inhibits prostate cancer cell growth by modulating the
COX-2 pathway in vivo. Cancer Prev Res (Phila). 4:1073–1083. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Young LE, Moore AE, Sokol L, Meisner-Kober
N and Dixon DA: The mRNA stability factor HuR inhibits microRNA-16
targeting of COX-2. Mol Cancer Res. 10:167–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
